Reglan - 60977-451-02 - (METOCLOPRAMIDE HYDROCHLORIDE)

Alphabetical Index


Drug Information of Reglan

Product NDC: 60977-451
Proprietary Name: Reglan
Non Proprietary Name: METOCLOPRAMIDE HYDROCHLORIDE
Active Ingredient(s): 5    mg/mL & nbsp;   METOCLOPRAMIDE HYDROCHLORIDE
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Reglan

Product NDC: 60977-451
Labeler Name: Baxter Healthcare Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA017862
Marketing Category: NDA
Start Marketing Date: 20101209

Package Information of Reglan

Package NDC: 60977-451-02
Package Description: 25 VIAL, SINGLE-DOSE in 1 CARTON (60977-451-02) > 10 mL in 1 VIAL, SINGLE-DOSE (60977-451-71)

NDC Information of Reglan

NDC Code 60977-451-02
Proprietary Name Reglan
Package Description 25 VIAL, SINGLE-DOSE in 1 CARTON (60977-451-02) > 10 mL in 1 VIAL, SINGLE-DOSE (60977-451-71)
Product NDC 60977-451
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name METOCLOPRAMIDE HYDROCHLORIDE
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20101209
Marketing Category Name NDA
Labeler Name Baxter Healthcare Corporation
Substance Name METOCLOPRAMIDE HYDROCHLORIDE
Strength Number 5
Strength Unit mg/mL
Pharmaceutical Classes Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC]

Complete Information of Reglan


General Information